St Michael's Hospital is a hospital in Bristol, England. Built in 1975, it provides maternity services for Bristol. The hospital is managed by University Hospitals Bristol and Weston NHS Foundation Trust.

During the past decade, St. Michael's Hospital conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St. Michael's Hospital" #1 sponsor was "Olympic Medical" with 1 trials, followed by "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 1 trials sponsored, "University Hospitals Bristol and Weston NHS Foundation Trust" with 1 trials sponsored, "University of Birmingham" with 1 trials sponsored and "University of Oxford" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St. Michael's Hospital" #1 collaborator was "Barts & The London NHS Trust" with 1 trials as a collaborator, "Birmingham Women's NHS Foundation Trust" with 1 trials as a collaborator, "City Hospitals Sunderland NHS Foundation Trust" with 1 trials as a collaborator, "Heart of England NHS Trust" with 1 trials as a collaborator and "King's College Hospital NHS Trust" with 1 trials as a collaborator. Other collaborators include 12 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "St. Michael's Hospital" are "Hypoxic Ischaemic Encephalopathy" (1 trials), "Late-onset Invasive Infection" (1 trials), "Missed Miscarriage" (1 trials), "Necrotizing Enterocolitis" (1 trials) and "Neonatal Hypoxic-Ischemic Encephalopathy (HIE)" (1 trials). Many other conditions were trialed in "St. Michael's Hospital" in a lesser frequency.

Most popular intervention types in "St. Michael's Hospital" are "Drug" (3 trials), "Device" (1 trials), "Dietary Supplement" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cool-Cap" (1 trials), "Mifepristone, Oral, 200 Mg" (1 trials), "Milk feed (breast milk or formula milk)" (1 trials), "Placebo Oral Tablet" (1 trials) and "Whole body cooling" (1 trials). Other intervention names were less common.

The vast majority of trials in "St. Michael's Hospital" are 4 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "St. Michael's Hospital". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in St. Michael's Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in St. Michael's Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".